Responses

PDF

Screening for chronic kidney disease in a community-based diabetes cohort in rural Guatemala: a cross-sectional study
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Underestimation of chronic kidney diseasein persons with diabetes: ACE inhibitors and albuminuria
    • Revathi Ulaganeethi, Public Health Specialist Independent Consultant
    • Other Contributors:
      • Yamini Marimuthu, Resident
      • Pruthu Thekkur, Monitoring and Evaluation Officer

    Dear authors,

    We read the article titled "Screening for chronic kidney disease in a community-based diabetes cohort in rural Guatemala: a cross-sectional study" published in BMJ Open. The article summoned our interest as your research work is very much relevant to the operational research in the field of diabetes. The studies in the past have consistently reported, early screening for diabetes complications, risk stratification and adhering to management guidelines are the mainstay to reduce premature mortality. As estimates show almost 20% of all ESRD cases may be attributed to diabetes alone, the targeted screening for CKD among diabetes patients becomes imperative.1

    Though renal complications of diabetes are known to be common among persons with diabetes, there are no global estimates of burden and yield of targeted screening. Most of the data regarding the burden of CKD among diabetics is from isolated studies mostly from high-income countries.2 These studies have shown varied estimates based on the criteria’s, standards and techniques used to determine CKD in each of these studies. Also, a majority of the studies were based in tertiary care facilities and might have failed to report the real burden of the disease of interest in the risk group. In its latest guidelines, American Diabetes Association (ADA) recommended screening for Diabetes Kidney Disease through assessment of albuminuria and estimated glomerular filtration rate in all patients...

    Show More
    Conflict of Interest:
    None declared.